Pharmafile Logo
Pharmafocus logo
Advanced Search

Lundbeck takes risk on Parkinson’s treatment, €905m on table

March 19, 2018
Sales and Marketing Lundbeck, Parkinson's, biotech, drugs, pharma, pharmaceutical

CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take …

News
shutterstock_57369385

India’s Narcotics Control Bureau seizes 55,000 zolpidem tablets in drugs bust

March 19, 2018
Manufacturing and Production, Sales and Marketing India, Narcotics Control Bureau, pharma

India’s drug agency, the Narcotics Control Bureau (NCB), has shut down an illegal trafficking racket in the country in a …

News

Pfizer to hang onto CEO, after 61% pay increase

March 19, 2018
Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten

Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …

News

Rising levels of opioid prescriptions puts NHS under pressure

March 16, 2018
Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical

It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …

News

NICE recommends Keytruda via CDF as first and only urothelial carcinoma immunotherapy

March 16, 2018
Medical Communications, Sales and Marketing MSD, NICE, immunotherapy, keytruda, pharma

UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through …

News

Allergan navigating choppy waters, as shares rise and fall

March 16, 2018
Medical Communications Allergan, Brent Saunders, biotech, drugs, pharma, pharmaceutical

By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …

News
ears-2545756_960_720

Hearing drug failure puts biotech on brink

March 16, 2018
Medical Communications, Research and Development Auris, biotech, drugs, pharma, pharmaceutical

Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …

News
12_rare

The need for flexible appraisal of rare disease medicines

March 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …

Feature
humacao_exterior

BMS restructure will transfer 90 jobs from NY state to Massachusetts and New Jersey

March 15, 2018
Manufacturing and Production BMS, Bristol-Myers Squibb, Massachusetts, New York, new jersey, pharma

Bristol-Myers Squibb has announced plans to relocate around 90 roles from the state of New York to facilities in Massachusetts …

News
fda_sign_web

Solid Biosciences rocked by clinical hold, shareholders flee

March 15, 2018
Research and Development Solid Biosciences, biotech, drugs, pharma, pharmaceutical

Solid Biosciences raised more than a few eyebrows when it only revealed a partial hold from the FDA stalling its …

News
william_pao

Roche appoints new research and early development head

March 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, appointment

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …

Appointment
obese-3011213_960_720

Fat-fighting pharma business files for bankruptcy

March 15, 2018
Sales and Marketing Contrave, biotech, drugs, orexigen, pharma, pharmaceutical

Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it …

News

Andrew Witty takes on a new CEO position

March 15, 2018
Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical

Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …

News
veeva_event

Top 5 Reasons Why You Should Attend Veeva R&D Summit, Europe

March 15, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and …

News
saroukos

Takeda’s CFO departs forcing company to act

March 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …

Appointment
teva_copy

Teva denies wrongdoing in Cephalon pay-to-delay deal hearing

March 14, 2018
Research and Development, Sales and Marketing Cephalon, Pay to delay, Provogil, Teva, pay-to-delay, pharma

Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …

News
philip_hammond

Hammond suggests NHS may receive cash boost

March 14, 2018
Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical

The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …

News
architect_of_the_capitol

US “right to try” experimental drug bill defeated in House vote

March 14, 2018
Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma

The divisive and much-talked-about “right to try” legislation designed to provide access for terminally ill Americans to experimental and unproven …

News
pills-384846_960_720

World’s first synthetic, non-biologic vaccine developed

March 14, 2018
Research and Development Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026